This document provides an overview of public health guidance aimed to ensure that the needs of refugees in relation to viral hepatitis are appropriately met, for all stages along the continuum of care from prevention through to treatment.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2022 and includes updates on COVID-19, Influenza, the Omicron variant, poliomyelitis and mass gathering monitoring for the Winter Olympic Games in Beijing.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 June-3 July 2021 and includes updates on the UEFA European Football Championship 2020 (2021), Vibrio growth in the Baltic Sea, COVID-19, Monkeypox, West Nile virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Chikungunya, Dengue and Poliomyelitis.
In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.
This brief will present a snapshot of hepatitis B and C testing in the European Union/European Economic Area (EU/EEA), discussing progress made towards the European action plan 2020 testing target, focussing on key populations and settings for testing, barriers to testing, and testing policies.
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.